Serum sodium, renal function, and survival of patients with end-stage liver disease. - Wikidata - awgldk - TriplyDB

Serum sodium, renal function, and survival of patients with end-stage liver disease.

Serum sodium, renal function, and survival of patients with end-stage liver disease.

http://www.wikidata.org/entity/Q35988332

about

Acute renal injury after partial hepatectomy Gender-based disparities in access to and outcomes of liver transplantation Ischemia/reperfusion, does temperature matter? Laboratory perspective.Prevalence of renal dysfunction in patients with cirrhosis according to ADQI-IAC working party proposal.Renal dysfunction in patients with cirrhosis: Where do we stand?Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?Model for end-stage liver disease: end of the first decade.The model for end-stage liver disease score-based system predicts short term mortality better than the current Child-Turcotte-Pugh score-based allocation system during waiting for deceased liver transplantation Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.Evaluation of renal function in patients with cirrhosis: where are we now?Significance of hypo- and hypernatremia in chronic kidney disease.Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites.Important predictor of mortality in patients with end-stage liver disease.Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia.Model for end-stage liver disease score and MELD exceptions: 15 years later.Impact of dynamic changes in MELD score on survival after liver transplantation - a Eurotransplant registry analysis.New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine?Performance of methods to assess kidney function in a predominantly overweight sample of patients with liver disease.Hot-topic debate on kidney function: renal-sparing approaches are beneficial.Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.

P2860

Q26740331-9D564B9D-415D-4992-A994-23DE454BABB0 Q28083778-CB0932BD-E558-4128-9378-CE1CE2CAF592 Q30278761-34067480-B69A-4E56-BF85-B842CE0317CA Q33905612-CC155A74-645A-4C71-A130-54A70267DA8F Q34047665-EA1E7CF5-C6C0-4627-B4B8-8406D7F50D6E Q35673289-22CF6E49-A61C-4EBC-801A-06D962354E1F Q36507944-E507CC64-FC96-4E1B-B81E-9DDA0646E807 Q36588122-278319F2-70A5-42BF-AC99-69E3704DDBA9 Q37098099-F3DE952C-41BF-4095-AEAB-E0A08E1FDC31 Q37593985-9627FCC2-3AAB-48CA-9058-A9A6C44737D9 Q37629678-68E1F042-D9E4-423A-A2FB-EB0A019B0D77 Q37989443-FAE763C9-3DE8-4305-B1F2-B54C56E685A6 Q38002958-1A742098-3576-4568-9B8C-2A28A2E1AEF8 Q38120248-1A46AA7D-BB20-4C53-910B-D373D6409B55 Q38354966-09EFB143-2A0D-4A66-9C22-C639269A6284 Q38504284-6638AE78-69F3-4FA8-9C31-528257576D27 Q40058139-F68F51C8-8ED8-4E14-AA77-DF4BC5A60E67 Q49097283-7507BE57-B6DF-440A-A030-2C9CB7EBE199 Q51297508-48340F62-F87D-44AB-8EF3-21396C35A170 Q51691293-A1FBB220-9490-4A09-9118-EB29C81450D3 Q51830649-55094017-BDF9-4944-B4A8-89825282F456

P2860

Serum sodium, renal function, and survival of patients with end-stage liver disease.

http://www.wikidata.org/entity/Q35988332

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@ast

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@en

type

label

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@ast

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@en

prefLabel

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@ast

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@en

P1433

Q35988332-343B2E47-1BB8-446F-BD1D-904644088ADB

P1476

Q35988332-808C70D5-C8AE-4184-90D9-4DAC091A0760

P2093

Q35988332-13F3F89C-36E4-4334-A7A5-581625912CD3

Q35988332-5DCFDA1D-CFD7-4EF9-A8C9-E58EDCFE5CF2

Q35988332-7BE2FC5F-0B3A-4A40-B71E-187DEC9FBCF7

Q35988332-9A6241FD-4237-46F8-B7E8-97B5047DD1B1

Q35988332-BDDE88BF-22C6-43EA-BE7C-5534D26255EF

Q35988332-D069A6A0-68A1-4D26-89CB-B4F27A2039EE

Q35988332-FA3FFB3D-8CBA-4BB7-B36D-41316337B1B4

P2860

Q35988332-0C2736AC-02AD-4E74-994E-5DD3553D19CD

Q35988332-135A854F-5BCD-4B8F-971A-003B16E5B05D

Q35988332-2C522AF4-E6BE-4964-AA0B-6C4FE659B836

Q35988332-4906481B-0EA7-4608-934A-743013FC781D

Q35988332-55F71A0E-7DB0-41C2-A6D6-1A9F54B58988

Q35988332-5C6C086E-8DBA-4A19-AFA8-1360F62B667D

Q35988332-5D20839F-7847-498E-B776-78E21037DECC

Q35988332-7182B2A7-284D-403A-A786-ED10F8DB3863

Q35988332-7265F45B-E5B5-4E95-9066-32C0229EBDE1

Q35988332-784778BA-4CD5-4AF1-82AE-D3721226D4FF

P304

Q35988332-745DFB5F-5D3A-48D5-A818-7866274962E0

P31

Q35988332-B161B4DE-D10C-4D57-BA0F-B04D73FD3D41

P356

Q35988332-0F0BEED1-8BFB-4078-8BF4-1F26B1EB342E

P433

Q35988332-BE7A00C6-5607-43D9-B5E5-6D8FF7E039F2

P478

Q35988332-D4026F05-CE16-4BEA-A720-88B8D3E4E599

P577

Q35988332-48CFE8C5-0114-441D-B069-D8428DDE7853

P698

Q35988332-30198931-D8A4-49A2-A7F6-FCA210547B39

P932

Q35988332-8EB7CC7C-8678-46FA-B1A6-FD1D41588883

P356

J.JHEP.2010.01.009

P1433

Journal of Hepatology

P1476

Serum sodium, renal function, and survival of patients with end-stage liver disease.

@en

P2093

Joanne T Benson

http://www.w3.org/2001/XMLSchema#string

Patrick S Kamath

http://www.w3.org/2001/XMLSchema#string

Terry M Therneau

http://www.w3.org/2001/XMLSchema#string

Timothy S Larson

http://www.w3.org/2001/XMLSchema#string

W Ray Kim

http://www.w3.org/2001/XMLSchema#string

Walter K Kremers

http://www.w3.org/2001/XMLSchema#string

Young-Suk Lim

http://www.w3.org/2001/XMLSchema#string

P2860

A model to predict survival in patients with end-stage liver disease

The model for end-stage liver disease (MELD)

A prognostic model for predicting survival in cirrhosis with ascites.

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.

Model for end-stage liver disease (MELD) and allocation of donor livers.

Electrolyte and circulatory changes in terminal liver failure.

Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.

Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.

P304

523-528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2010.01.009

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2010-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20185195

http://www.w3.org/2001/XMLSchema#string

P932

4546826

http://www.w3.org/2001/XMLSchema#string